Eledon Pharmaceuticals (2TK) Income Statement
Eledon Pharmaceuticals Income Statement
Last quarter (Q2 2026), Eledon Pharmaceuticals's total revenue was $0.00. In Q2, Eledon Pharmaceuticals's net income was $-31.63M. See Eledon Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ 83.25M | $ 70.58M | $ 43.00M | $ 88.43M | $ 36.87M | |
| Depreciation and Amortization | $ 313.00K | $ 359.00K | $ 374.00K | $ 373.00K | $ 195.00K |
| $ -45.27M | $ -35.39M | $ -116.16M | $ -39.41M | $ -36.66M | |
| $ -83.25M | $ -70.58M | $ -43.00M | $ -88.43M | $ -36.87M | |
| $ 37.67M | $ 34.82M | $ -73.54M | $ 462.00K | $ 7.00K | |
| $ -45.58M | $ -35.75M | $ -116.54M | $ -87.97M | $ -36.86M | |
| $ -45.62M | $ -36.18M | $ -116.54M | $ -87.97M | $ -34.51M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.56 | $ -0.75 | $ -4.73 | $ -6.16 | $ -2.33 |
| Diluted EPS | $ -0.56 | $ -0.75 | $ -4.73 | $ -6.16 | $ -2.33 |
| Weighted Average Shares Outstanding | 81.84M | 48.54M | 24.62M | 14.29M | 14.82M |
| Weighted Average Shares Outstanding (Diluted) | 81.84M | 48.54M | 24.62M | 14.29M | 14.82M |
Currency in USD